About

Provided by McDermott Will & Schulte

McDermott Will & Emery’s highly experienced Texas Corporate M&A practice offers market leading expertise across the full spectrum of transactions. The firm dominates the middle to upper-middle market arena, typically advising on high-profile, challenging transactions, in the USD 50 million to USD 10 billion range.

McDermott Will & Emery’s Texas Corporate M&A practice offers deep industry insight, with particularly impressive track record in the health care and life sciences, technology, private equity, professional services, chemicals, and food and beverage sectors. The firm has one of the largest and most prestigious health law practices in the United States. The Texas Corporate M&A practice excels in advising strategic buyers and private equity investors in the acquisition and sale of companies, business units, and service lines involving health care services and technologies.

McDermott Will & Emery’s Texas Corporate M&A practice offers impressive national and international reach. The team regularly leverages the firm’s extensive global resources, with 220 corporate and M&A lawyers located across the country and beyond. This enables the team to provide a highly coordinated, seamless service to clients on challenging cross-border issues.

Chambers Review

Provided by Chambers

Corporate/M&A: Highly Regarded - Texas

1
Band 1

What the Team is Known For

McDermott Will & Schulte is noted for its skills in handling midmarket M&A. The firm has strong expertise in the healthcare and technology space. It frequently advises on private equity as well as public company transactions.

Work Highlights

  • McDermott Will & Schulte represented Cognizant Technology Solutions in its acquisition of Thirdera Holdings, LLC.

Strengths

Provided by Chambers

Members

Provided by McDermott Will & Schulte

Diego Gómez-Cornejo

Joanna Jung-Erh Lin

Lindsey Reighard